Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
120
Trial Sponsor
Clinical Trial Start Date
2015
0Primary Completion Date
2015
0Study Completion Date
2015
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Other0
Intervention Type
Drug0
Intervention Name
Celecoxib0
AKB-65480
Interventional Trial Phase
Phase 10
Official Name
An Open-label Study in Healthy Subjects to Assess the Effect of Once-daily Multiple Dosing of AKB-6548 on the Pharmacokinetics of the CYP2C9 Substrate Celecoxib0
Last Updated
November 14, 2018
0Allocation Type
Randomized0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
To assess the single dose pharmacokinetics (PK) of celecoxib in healthy subjects when administered alone and following multiple daily doses of AKB-6548.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
